Publication / Source: Biomarkers in Medicine 3(6)
Authors: Boutouyrie B
“…the societal pressure for individualized medicine is indeed a powerful engine to provoke adaptation of clinical pharmacologists and the science of clinical pharmacology.”
Lew Sheiner spent a 7-month sabbatical stay in the company where I was working as a Clinical Pharmacologist 15 years ago. After this, he wrote a key paper entitled ‘Learning versus confirming in clinical drug development’ . Lew foresaw that in the not-too-distant future, pharmaceutical companies would not only sell drugs with printed labeling but drugs with a software to guide the prescribers on the key elements to identify the right drug, the right dose in the right patient with the right disease as guided by the right biomarkers!